Abstract
Aim: This study assessed treatment outcomes of Helicobacter pylori (H pylori) infection among inner-city children. Methods: This was a retrospective study of patients aged 1-21 years who underwent initial treatment for H pylori infection from 2011 to 2015. We included patients who completed 2 weeks of treatment with documented adequate compliance after H pylori infection was diagnosed. Treatment outcomes were measured based on stool H pylori antigen and/or histology. Results: Of the total 261 patients diagnosed with H pylori, 239 completed the first-line treatment. The regimens used included amoxicillin/clarithromycin/proton pump inhibitor (PPI) in 207/239 patients (86.6%), amoxicillin/metronidazole/PPI in 14/239 patients (5.8%) and other regimens in 18/239 patients (7.5%). H pylori eradication status was tested in 111/207 (53.6%) patients treated with amoxicillin/clarithromycin/PPI, and the eradication was achieved in 84/111(75.7%) patients. The treatment success rates for amoxicillin/metronidazole/PPI and other regimens were 71.4% (5/7) and 63.6% (7/11), respectively. There was no statistical significance of post-treatment stool H pylori antigen results between PPI (n = 31) and no PPI (n = 43) users. Conclusion: The study showed an eradication rate of 75.7% with the regimen amoxicillin/clarithromycin/PPI suggesting significant antibiotic resistance in our population. The use of PPI did not influence post-treatment stool H pylori antigen results.
Original language | English (US) |
---|---|
Pages (from-to) | 1860-1866 |
Number of pages | 7 |
Journal | Acta Paediatrica, International Journal of Paediatrics |
Volume | 109 |
Issue number | 9 |
DOIs | |
State | Published - Sep 1 2020 |
Keywords
- Helicobacter pylori infection
- children
- treatment outcome
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health